Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pemigatinib + Afatinib in Advanced Refractory Solid Tumors	Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm	Recruiting	Phase 1	2026-09-23		NCT06302621

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Boehringer Ingelheim	158
Incyte Corporation	153
Massachusetts General Hospital	758

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Massachusetts General Hospital	Boston	United States	39

Clinical trials